Director's Corner
Share:
The Corner Post
RADx Tech accelerates FDA authorization of first point-of-care hepatitis C test
The NIBIB Director Dr. Bruce Tromberg discusses the latest accomplishment by the RADx Tech Independent Test Assessment Program with the authorization of the first point-of-care hepatitis C virus diagnostic test.
Previous Corner Posts
RADx Initiative: Bioengineering for COVID-19 at Unprecedented Speed and Scale
NIBIB Director Dr. Bruce Tromberg marks the two-year anniversary of RADx® Tech, and takes a brief look back at its formation, impact, and potential for future growth.
Bridge2AI: Call to the bioengineering community
NIBIB is proud to be one of the co-sponsors of the exciting new NIH Common Fund initiative Bridge2AI which aims to dramatically advance widespread adoption of artificial intelligence (AI) as a tool for biomedical research.
RADx One Year Later – A Sea Change for Diagnostics
A quiet healthcare revolution is taking place, driven by an urgent national need and fueled by cutting-edge technologies. Diagnostics have changed, and more COVID-19 tests are now performed in point of care (POC) and home settings than in central labs. NIBIB is now looking forward with the goal of leveraging this unprecedented transformation.
Director's Corner Events and Appearances
NIBIB Director Keynote on Accelerating Innovation and Technology Development in IR and AI
Watch Dr. Bruce Tromberg's talk on Accelerating Innovation and Technology Development in IR and AI through Engineering-Medicine Partnerships.
Dr. Tromberg addresses MedTech 2024 on Capitol Hill
Dr. Tromberg provided welcoming remarks at the 12th Annual Academy Medical Imaging Technology Showcase, held March 5, 2024, on Capitol Hill.
NIBIB Director Elected to National Academy of Engineering
NIBIB Director Dr. Bruce Tromberg was elected to the 2024 class of the National Academy of Engineering (NAE) for leading the institute in its response to the global pandemic and creating innovative diagnostics.